Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 436–450 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4359 MAP2K1 Gene Analysis for Cardiofaciocutaneous Syndrome Type 3 (CFC3) Test This test identifies pathogenic variants in the MAP2K1 gene associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3). It uses Next-Generation Sequencing (NGS) on DNA extracted f...	Peripheral Whole Blood (EDTA) or Extracted DNA	14 – 21 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MAP2K1 gene pathogenic variants", "Single nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of Cardiofaciocutaneous Syndrome Type 3 (CFC3)", "RASopathy spectrum disorder evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 77080-0 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the MAP2K1 gene associated with Cardiofaciocutaneous Syndrome Type 3 (CFC3). It uses Next-Generation Sequencing (NGS) on DNA extracted from peripheral blood.
TEST-4377 MAP2K2 Gene Sequencing Test for Cardiofaciocutaneous Syndrome Type 4 (CFC4) This test identifies pathogenic variants in the MAP2K2 gene, confirming a diagnosis of Cardiofaciocutaneous Syndrome Type 4 (CFC4).	Peripheral whole blood or FTA card finger-prick	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MAP2K2 gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Cardiofaciocutaneous Syndrome Type 4 (CFC4)", "Family history of CFC syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.89 Clinical summary This test identifies pathogenic variants in the MAP2K2 gene, confirming a diagnosis of Cardiofaciocutaneous Syndrome Type 4 (CFC4).
TEST-4861 MBTPS2 Gene Analysis (Keratosis Follicularis Spinulosa Decalvans, X-Linked) Test This test analyzes the MBTPS2 gene for pathogenic variants associated with X-linked Keratosis Follicularis Spinulosa Decalvans.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MBTPS2 gene sequence", "Pathogenic variants (point mutations, indels, CNVs)"] Parameters [] Preparation ["Mandatory genetic counselling session required before sample collection", "No fasting required"] Indications ["Diagnosis of X-linked Keratosis Follicularis Spinulosa Decalvans", "Carrier screening for X-linked Keratosis Follicularis Spinulosa Decalvans"] Measurement technique Confirm with laboratory Codes LOINC: 81247-1 ICD-10: Q82.8, L66.1, Z15.89 Clinical summary This test analyzes the MBTPS2 gene for pathogenic variants associated with X-linked Keratosis Follicularis Spinulosa Decalvans.
TEST-5922 MCCC1 Gene 3-Methylcrotonyl-CoA Carboxylase 1 Deficiency Genetic Test This test identifies mutations in the MCCC1 gene associated with 3-methylcrotonyl-CoA carboxylase deficiency.	Whole blood (venous) or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MCCC1 gene mutations"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Individuals with suspicious symptoms", "Family history of the disorder", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 82309-2 ICD-10: E71.120 Clinical summary This test identifies mutations in the MCCC1 gene associated with 3-methylcrotonyl-CoA carboxylase deficiency.
TEST-3688 MCM4 Gene Immunodeficiency with Natural Killer Cell Deficiency Genetic Test This genetic test evaluates the MCM4 gene for pathogenic variants associated with primary immunodeficiency affecting natural killer cell development and function.	Peripheral whole blood (3–5 mL EDTA tube) or FTA card dried blood spot	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MCM4 gene", "Single nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation [] Indications ["Suspected primary immunodeficiency", "Recurrent severe viral infections", "Lymphopenia", "Family history of immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 94222-7 ICD-10: D84.9, Z15.09 Clinical summary This genetic test evaluates the MCM4 gene for pathogenic variants associated with primary immunodeficiency affecting natural killer cell development and function.
TEST-6078 MCM6 Gene Lactose Intolerance Adult Type Genetic Test This genetic test evaluates the MCM6 gene for variants associated with adult-type lactase non-persistence (lactose intolerance).	Whole blood, extracted DNA, or FTA card (dried blood spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["rs4988235 variant in the MCM6 gene", "Lactase persistence/non-persistence status"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed before the test"] Indications ["Suspected primary adult-type lactose intolerance", "Personal or family history of lactose intolerance", "Guidance for dietary management"] Measurement technique Confirm with laboratory Codes LOINC: 94605-3 ICD-10: E73.9 Clinical summary This genetic test evaluates the MCM6 gene for variants associated with adult-type lactase non-persistence (lactose intolerance).
TEST-5945 MCOLN1 Gene Mucolipidosis Type IV (ML4) Genetic Test This genetic test identifies pathogenic variants in the MCOLN1 gene, which are associated with Mucolipidosis Type IV (ML4). It is used for diagnosis, carrier screening, and prenata...	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 weeks (expedited option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MCOLN1 gene", "Presence of mutations associated with ML4"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist of anticoagulant therapy"] Indications ["Suspected clinical diagnosis of Mucolipidosis Type IV", "Family history of ML4", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81346-7 ICD-10: E75.11 Clinical summary This genetic test identifies pathogenic variants in the MCOLN1 gene, which are associated with Mucolipidosis Type IV (ML4). It is used for diagnosis, carrier screening, and prenatal risk assessment.
TEST-3400 MDM2 Gene (Accelerated Tumor Formation Susceptibility) Genetic Test This genetic test evaluates the MDM2 gene for variants associated with an increased susceptibility to developing certain types of cancer.	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA (≥1 µg)	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MDM2 gene variants (germline and somatic)", "Copy Number Variations (CNV) in MDM2"] Parameters [{"name": "MDM2 Gene Variants", "reference_range": "No pathogenic variants detected"}] Preparation ["Mandatory genetic counselling session before sample collection", "Informed consent required"] Indications ["Patients with a personal or family history of hematologic or solid organ malignancies", "Risk stratification for cancer surveillance"] Measurement technique Confirm with laboratory Codes LOINC: 90542-4 ICD-10: Z15.09 Clinical summary This genetic test evaluates the MDM2 gene for variants associated with an increased susceptibility to developing certain types of cancer.
TEST-1394 MDM2 Gene Amplification FISH Test This diagnostic test evaluates the number of copies of the MDM2 gene in tumor tissue using Fluorescence In-Situ Hybridization (FISH). It specifically looks for amplification, which...	Archival Tissue Specimen (FFPE Block or Slides)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MDM2 gene copy number", "Gene amplification"] Parameters [] Preparation [] Indications ["Diagnosis of well-differentiated/dedifferentiated liposarcomas", "Guiding targeted therapy for MDM2-amplified tumors"] Measurement technique Confirm with laboratory Codes LOINC: 21795-0 ICD-10: C49.9 Clinical summary This diagnostic test evaluates the number of copies of the MDM2 gene in tumor tissue using Fluorescence In-Situ Hybridization (FISH). It specifically looks for amplification, which means an increased number of copies of the gene compared to normal cells.
TEST-2989 MECP2 Gene Analysis (CCHS) Test This test identifies pathogenic variants in the MECP2 gene associated with congenital central hypoventilation syndrome (CCHS).	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MECP2 coding regions", "Pathogenic variants in MECP2 splice sites"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected congenital central hypoventilation syndrome (CCHS)", "Infants or children with unexplained breathing problems", "Family history of CCHS"] Measurement technique Confirm with laboratory Codes LOINC: 53044-2 ICD-10: G47.35 Clinical summary This test identifies pathogenic variants in the MECP2 gene associated with congenital central hypoventilation syndrome (CCHS).
TEST-4793 MECP2 Gene Duplication Syndrome (Lubs Type) Genetic Test This genetic test analyzes the MECP2 gene for duplications, deletions, and point mutations to diagnose Lubs syndrome.	Peripheral whole blood (EDTA), Dried blood spot (FTA card), Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy Number Variants (CNV) in MECP2 gene", "Point mutations in MECP2 gene"] Parameters [] Preparation ["No fasting required"] Indications ["Unexplained developmental delay", "Hypotonia", "Recurrent infections in male patients", "Suspected Lubs syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 82117-7 ICD-10: Q99.8, Z15.89, G93.89 Clinical summary This genetic test analyzes the MECP2 gene for duplications, deletions, and point mutations to diagnose Lubs syndrome.
TEST-2475 MED12 Gene Sequencing for Opitz-Kaveggia Syndrome (NGS) Test This test identifies mutations within the MED12 gene associated with Opitz-Kaveggia syndrome.	Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MED12 gene coding region mutations"] Parameters [] Preparation ["No fasting or special preparation required"] Indications ["Suspected Opitz-Kaveggia syndrome", "Family planning for X-linked disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81231-1 ICD-10: Q87.8 Clinical summary This test identifies mutations within the MED12 gene associated with Opitz-Kaveggia syndrome.
TEST-4858 MED23 Gene Autosomal Recessive Intellectual Disability Type 18 (MRT18) Genetic Test This genetic test identifies pathogenic variants, including deletions and duplications, within the MED23 gene associated with autosomal recessive intellectual disability type 18.	Whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks (fast-track available upon request)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MED23 gene sequence variants", "MED23 gene deletions/duplications"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical suspicion of autosomal recessive intellectual disability type 18 (MRT18)", "Carrier screening for individuals with a family history of MRT18", "Family planning for couples at risk of having a child with MRT18"] Measurement technique Confirm with laboratory Codes LOINC: 93859-0 ICD-10: Q87.8 Clinical summary This genetic test identifies pathogenic variants, including deletions and duplications, within the MED23 gene associated with autosomal recessive intellectual disability type 18.
TEST-1606 MEFV Full Gene Sequencing Test This test identifies mutations within the MEFV gene associated with Familial Mediterranean Fever.	Peripheral whole blood (EDTA tube)	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MEFV gene mutations", "Presence of pathogenic variants"] Parameters [] Preparation ["No fasting required", "Bring valid DHA-approved doctor’s prescription", "Bring Emirates ID"] Indications ["Suspected Familial Mediterranean Fever", "Recurrent unexplained febrile episodes", "Family history of FMF", "Asymptomatic siblings of confirmed FMF cases"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E85.0 Clinical summary This test identifies mutations within the MEFV gene associated with Familial Mediterranean Fever.
TEST-6006 MEFV Gene Familial Mediterranean Fever Genetic Test This test evaluates the MEFV gene for mutations associated with Familial Mediterranean Fever (FMF). It uses Next-Generation Sequencing (NGS) to provide comprehensive analysis.	Whole Blood (EDTA) or DNA Sample (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MEFV gene mutations", "Copy Number Variations (CNVs) in MEFV gene", "Rare intronic variants in MEFV gene"] Parameters [] Preparation ["No specific fasting required", "Do not alter prescribed therapy without medical consultation"] Indications ["Confirmation of clinical diagnosis of Familial Mediterranean Fever (FMF)", "Identification of carrier status in family members", "Predictive testing for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 56762-6 ICD-10: M04.1 Clinical summary This test evaluates the MEFV gene for mutations associated with Familial Mediterranean Fever (FMF). It uses Next-Generation Sequencing (NGS) to provide comprehensive analysis.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.